Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Company Overview

Arctos NorthStar Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on sports, media, and entertainment sectors. The company was founded in 2020 and is based in Dallas, Texas.

Key Stats

• Today's Range: $10.19 to $10.19
• 50-Day Range: $9.68 to $9.79
• 52-Week Range: $9.44 to $10.20
• Volume: 705 shs
• Average Volume: 53,611 shs
• Market Capitalization: $402.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ANAC Stock Analysis - Frequently Asked Questions

How were Arctos NorthStar Acquisition's earnings last quarter?

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) issued its quarterly earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. The business's revenue was up 14.9% compared to the same quarter last year.

What other stocks do shareholders of Arctos NorthStar Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Arctos NorthStar Acquisition investors own include Portola Pharmaceuticals (PTLA), Micron Technology (MU), Bristol-Myers Squibb (BMY), bluebird bio (BLUE), Netflix (NFLX), Palo Alto Networks (PANW) and BioMarin Pharmaceutical (BMRN).

Company Calendar

• Last Earnings: 5/10/2016
• Today: 5/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Holding & other investment offices
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:ANAC
• CIK: 1411158
• Web: www.anacor.com
• Phone: 972-918-3800
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $7.16 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -70.78%
• Return on Assets: 3.97%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.15
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.18 per share
• Price / Cash Flow: 56.23
• Book Value: ($0.63) per share
• Price / Book: -16.17

Miscellaneous

• Outstanding Shares: 39,530,000
• Free Float: N/A
• Market Cap: $402.81 million
• Optionable: Not Optionable
• Beta: N/A